DUBLIN–(BUSINESS WIRE)–The “Central
Nervous System – Disease & Epidemiology Overview” report
from Decision Resources Group has been added to ResearchAndMarkets.com’s
This report provides a disease market overview for each indication and
global epidemiology overviews for each indication.
The Central Nervous System Disease & Epidemiology Overview report
provides disease market overviews and global epidemiology overviews for
28 indications in the Central Nervous System therapy area:
Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Autism, Epilepsy,
Friedreich’s Ataxia, Huntington’s Disease, Ischemic Stroke, Multiple
Sclerosis, Muscular Dystrophy, Parkinson’s Disease, Spinal Muscular
Atrophy, Traumatic Brain Injury, Cancer Pain, Chronic Low Back Pain,
Chronic Pain, Migraine, Neuropathic Pain, Osteoarthritic Pain,
Postoperative Pain, Attention-Deficit-Hyperactivity Disorder, Bipolar
Disorder, Borderline Personality Disorder, Narcolepsy,
Obsessive-Compulsive Disorder, Opioid Addiction, Post Traumatic Stress
Disorder, Schizophrenia and Unipolar Depression Disease.
The disease market overviews include information such as market size
forecasts, prevailing treatment trend analysis and predictions, key
areas of unmet need, current and emerging therapies, physician (KOL)
insights, clinical pipeline analysis, and more, for each indication.
The global epidemiology overviews provide insights including global
diagnosed prevalence, diagnosed prevalence by region, 10-year diagnosed
prevalence growth forecast, relative sizes of the factors contributing
to the trend in prevalent cases, and more, for each indication.
Key Topics Covered:
- About the Analyst
- About the analyst’s Epidemiology
- Disease Landscape and Insight Overview
- Epidemiology Overview
- Eli Lilly
For more information about this report visit https://www.researchandmarkets.com/research/knvckb/central_nervous?w=4